Return to home page

Upon conclusion of this course, participants should be able to:

• Define the role of newer antiviral medications in the treatment of viral hepatitis.
• Summarize the evolving management of cholestatic disorders.
• Describe the treatment approach to patients with inflammatory bowel disease.
• Identify current strategies for the management of Clostridium difficile infection.
• Differentiate the newer anticoagulation agents and their management in patients undergoing gastrointestinal endoscopy.
• Develop an approach to patients with esophageal motility disorders, including endoscopic treatment options for achalasia.
• Review options for colorectal cancer screening, including fecal DNA testing.
• Describe treatment options for irritable bowel syndrome.

Attendance at this Mayo course does not indicate nor guarantee competence or proficiency in the performance of any procedures which may be discussed or taught in this course.